Treatments for Oxidative Stress
s is a condition in wherein the ability of the body to detoxify or repair damage from reactive oxygen species is insufficient. This manifests itself in many diseases, including atherosclerosis, heart disease, inflammation and neurological disorders. Several companies are developing treatments for disease based on the mechanism of treating oxidative stress.
Guelph researchers have discovered that some short phosphopeptides have a strong ability to reduce oxidative stress in Caco-2 cells, as well as inhibit TNFalpha-induced cytokine release and insulin resistance.
- Short phosphopeptides could be used as a natural health product, which may represent a faster path to market
- Possibility to pursue a pharmaceutical indication
- Easy to manufacture
In vitro results show strong effect in Caco-2 cells
- Treatment of a variety of conditions that cause or are worsened by oxidative stress
- Possible use as a natural health product or as pharmaceutical cells, as well as inhibit TNF alpha-induced cytokine release and insulin resistance
Available for licensing.
Steve De Brabandere, firstname.lastname@example.org 519-824-4120 x54916